IGF-LR3 (1mg)

IGF-1 LR3 (IGFLR3) is a modified insulin-like growth factor-1 analogue developed for advanced cellular and molecular research. Structural modifications, including an extended N-terminal sequence, reduce binding to IGF-binding proteins, allowing researchers to study prolonged IGF-1 receptor signalling in controlled laboratory settings.

This enhanced receptor interaction profile has made IGF-1 LR3 widely used in studies examining cell growth pathways, protein synthesis signalling, and anabolic regulatory mechanisms.

Key Features

• Research-grade, high-purity peptide
• Modified IGF-1 structure with extended receptor interaction
• Reduced affinity for IGF-binding proteins (IGFBPs)
• Manufactured under cGMP conditions
• Batch-specific Certificate of Analysis (COA) provided
• Stable when stored under recommended conditions

Research Applications

• IGF-1 receptor signalling studies
• Cellular growth and proliferation research
• Protein synthesis and anabolic pathway investigation
• Comparative analysis versus native IGF-1
• In-vitro and ex-vivo research models

IGF-1 LR3 provides researchers with a valuable tool for exploring sustained IGF-1 pathway activation and its downstream biological signalling effects in laboratory environments.

For laboratory research use only. Not for human consumption.